Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24

2002/07/01 by Glen Brice, G Brice, Sahar Mansour +18 · 28 citations
Medicine · #Lymphatic System and Diseases #Vascular Malformations and Hemangiomas #Lymphatic Disorders and Treatments

paper · pdf · doi:10.1136/jmg.39.7.478

Abstract

INTRODUCTION: Lymphoedema-distichiasis syndrome (LD) (OMIM 153400) is a rare, primary lymphoedema of pubertal onset, associated with distichiasis. Causative mutations have now been described in FOXC2, a forkhead transcription factor gene. Numerous clinical associations have been reported with this condition, including congenital heart disease, ptosis, varicose veins, cleft palate, and spinal extradural cysts. SUBJECTS: We report clinical findings in 74 affected subjects from 18 families and six isolated cases. All of them were shown to have mutations in FOXC2 with the exception of one family who had two affected subjects with lymphoedema and distichiasis and linkage consistent with the 16q24 locus. RESULTS: The presence of lymphoedema was highly penetrant. Males had an earlier onset of lymphoedema and a significantly increased risk of complications. Lymphatic imaging confirmed the earlier suggestion that LD is associated with a normal or increased number of lymphatic vessels rather than the hypoplasia or aplasia seen in other forms of primary lymphoedema. Distichiasis was 94.2% penetrant, but not always symptomatic. Associated findings included ptosis (31%), congenital heart disease (6.8%), and cleft palate (4%). Other than distichiasis, the most commonly occurring anomaly was varicose veins of early onset (49%). This has not been previously reported and suggests a possible developmental role for FOXC2 in both venous and lymphatic systems. This is the first gene that has been implicated in the aetiology of varicose veins. CONCLUSION: Unlike previous publications, the thorough clinical characterisation of our patients permits more accurate prediction of various phenotypic abnormalities likely to manifest in subjects with FOXC2 mutations.

Cited by

• S1PR1 regulates lymphatic valve development and tertiary lymphoid organ formation in the ileum
• Equivalent missense variant in the FOXP2 and FOXP1 transcription factors causes distinct neurodevelopmental disorders
• Microcephaly, intellectual impairment, bilateral vesicoureteral reflux, distichiasis, and glomuvenous malformations associated with a 16q24.3 contiguous gene deletion and a Glomulin mutation
• Long-range control of gene expression: emerging mechanisms and disruption in disease. [europepmc]
• Tbx1 is regulated by forkhead proteins in the secondary heart field. [europepmc]
• Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. [europepmc]
• Gastrointestinal lymphatics in health and disease. [europepmc]
• Lymphatic vascular morphogenesis in development, physiology, and disease. [europepmc]
• Transcription factor pathways and congenital heart disease. [europepmc]
• Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins. [europepmc]
• Development of the mammalian lymphatic vasculature. [europepmc]
• New developments in clinical aspects of lymphatic disease. [europepmc]
• Identification of novel craniofacial regulatory domains located far upstream of SOX9 and disrupted in Pierre Robin sequence. [europepmc]
• Emerging trends in the pathophysiology of lymphatic contractile function. [europepmc]
• Foxc1 and Foxc2 deletion causes abnormal lymphangiogenesis and correlates with ERK hyperactivation. [europepmc]
• EPHB4 kinase-inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis. [europepmc]
• Yellow nail syndrome: a review. [europepmc]
• Human venous valve disease caused by mutations in FOXC2 and GJC2. [europepmc]
• Intraluminal valves: development, function and disease. [europepmc]
• Mechanisms of Connexin-Related Lymphedema. [europepmc]
• Lymphatic Vessel Network Structure and Physiology. [europepmc]
• Shear stimulation of FOXC1 and FOXC2 differentially regulates cytoskeletal activity during lymphatic valve maturation. [europepmc]
• The Lymphatic Vasculature in the 21 st Century: Novel Functional Roles in Homeostasis and Disease. [europepmc]
• Lymphatic Valves and Lymph Flow in Cancer-Related Lymphedema. [europepmc]
• Epidemiology and Genetics of Venous Thromboembolism and Chronic Venous Disease. [europepmc]
• Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins. [europepmc]
• Foxo1 deletion promotes the growth of new lymphatic valves. [europepmc]
• FOXC2 controls adult lymphatic endothelial specialization, function, and gut lymphatic barrier preventing multiorgan failure. [europepmc]

Related

• Rapid identification of mutations in GJC2 in primary lymphoedema using whole exome sequencing combined with linkage analysis with delineation of the phenotype
• The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings
• Update and audit of the St George’s classification algorithm of primary lymphatic anomalies: a clinical and molecular approach to diagnosis
• Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF Variant
• GATA2 is required for lymphatic vessel valve development and maintenance